Infection by TRIC agent and other members of the Bedsonia group; with a note on Reiter's disease. 3. Genital infection and disease of the eye.

PubWeight™: 1.35‹?› | Rank: Top 10%

🔗 View Article (PMID 5226585)

Published in Trans Ophthalmol Soc U K on January 01, 1966

Authors

E M Dunlop, M K al-Hussaini, A Freedman, J A Garland, I A Harper, B R Jones, J W Race, M S Du Toit, J D Treharne, D J Wright

Articles by these authors

Detection of Chlamydia (Bedsonia) in certain infections of man. I. Laboratory procedures: comparison of yolk sac and cell culture for detection and isolation. J Infect Dis (1969) 16.47

A simple system for the assessment of trachoma and its complications. Bull World Health Organ (1987) 12.27

Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science (1997) 8.90

Detection of Chlamydia (Bedsonia) in certain infections of man. II. Clinical study of genital tract, eye, rectum, and other sites of recovery of Chlamydia. J Infect Dis (1969) 6.76

Modification of the microimmunofluorescence test to provide a routine serodiagnostic test for chlamydial infection. J Clin Pathol (1977) 6.48

Chlamydial infection. Incidence in 'non-specific' urethritis. Br J Vener Dis (1972) 6.04

Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med (2001) 5.66

Blinding and non-blinding trachoma: assessment of intensity of upper tarsal inflammatory disease and disabling lesions. Bull World Health Organ (1975) 5.58

Postinfectious fatigue: prospective cohort study in primary care. Lancet (1995) 5.21

Population based study of fatigue and psychological distress. BMJ (1994) 5.15

Determinants of HIV-1 shedding in the genital tract of women. Lancet (2001) 5.10

Reduced lymphocyte transformation due to a plasma factor in patients with active syphilis. Lancet (1969) 4.92

Chlamydial infection. Improved methods of collection of material for culture from the urogenital tract and rectum. Br J Vener Dis (1972) 4.88

The prevention of blindness from trachoma. Trans Ophthalmol Soc U K (1975) 4.80

Infection by Bedsoniae and the possibility of spurious isolation. 2. Genital infection, disease of the eye, Reiter's disease. Am J Ophthalmol (1967) 4.73

Chlamydial infection. Results of micro-immunofluorescence tests for the detection of type-specific antibody in certain chlamydial infections. Br J Vener Dis (1972) 4.50

Conjunctival swabbing for the isolation of TRIC agent (Chlamydia). Br J Ophthalmol (1971) 4.01

Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. Lancet (1993) 3.72

Dehydrational crises from severe diarrhoea or heatstroke and risk of cataract. Lancet (1984) 3.70

Chlamydial infection. Advances in the diagnostic isolation of Chlamydia, including TRIC agent, from the eye, genital tract, and rectum. Br J Vener Dis (1972) 3.41

Rapid diagnosis of chlamydial infection of the cervix. Br J Vener Dis (1978) 3.35

Antibodies to Chlamydia trachomatis in acute salpingitis. Br J Vener Dis (1979) 3.32

Amoebic infection of the eye. Lancet (1974) 3.27

Mycoplasmas and "non-specific" genital infection. 3. Post-gonococcal urethritis. A prospective study. Br J Vener Dis (1969) 3.03

Cattle as a possible source of verocytotoxin-producing Escherichia coli O157 infections in man. Epidemiol Infect (1993) 2.94

Further characterization of prolymphocytic leukemia cells as a tumor of activated B cells. Am J Hematol (1990) 2.93

Urethritis due to Chlamydia trachomatis. Br J Vener Dis (1977) 2.91

Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers. Lancet (1979) 2.90

Chlamydia trachomatis and Neisseria gonorrhoeae infections in women attending inner city general practices. Br Med J (Clin Res Ed) (1983) 2.83

Human factors and cardiac surgery: a multicenter study. J Thorac Cardiovasc Surg (2000) 2.77

A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli O157 from bovine faeces. J Med Microbiol (1994) 2.46

Infection by TRIC agent and other members of the Bedsonia group; with a note on Reiter's disease. II. Ophthalmia neonatorum due to TRIC agent. Trans Ophthalmol Soc U K (1966) 2.46

Double-blind trial of the treatment of episcleritis-scleritis with oxyphenbutazone or prednisolone. Br J Ophthalmol (1966) 2.41

Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers. Am J Ophthalmol (1972) 2.37

Why is the infectious stage of syphilis prolonged? Br J Vener Dis (1974) 2.36

Isolation of chlamydia from the urethra of a woman. Br Med J (1972) 2.36

Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS) JAMA (2000) 2.33

Mycoplasmas and "non-specific" genital infection. I. Previous studies and laboratory aspects. Br J Vener Dis (1969) 2.32

Principles in the management of oculomycosis. XXXI Edward Jackson memorial lecture. Am J Ophthalmol (1975) 2.29

Effect of high-speed centrifugation on the sensitivity of irradiated McCoy cell culture for the isolation of Chlamydia. Br J Vener Dis (1974) 2.28

Rapid serological test for diagnosis of chlamydial ocular infections. Br J Ophthalmol (1978) 2.25

Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol (1985) 2.18

First year donation patterns predict long-term commitment for first-time donors. Vox Sang (2005) 2.18

Penicillin levels in blood and CSF achieved by treatment of syphilis. JAMA (1979) 2.17

Chlamydial infection. Results of tests for Chlamydia in patients suffering from acute Reiter's disease compared with results of tests of the genital tract and rectum in patients with ocular infection due to TRIC agent. Br J Vener Dis (1972) 2.15

Treatment of TRIC infection of the eye with rifampicin or chloramphenicol. Br J Ophthalmol (1977) 2.14

Punctate keratopathy of West Indians. Br J Ophthalmol (1968) 2.11

The management of ocular herpes. Trans Ophthalmol Soc U K (1967) 2.08

PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies. Hum Mol Genet (1999) 2.08

Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J (2001) 2.07

Results of complement-fixation and intradermal tests for Bedsoniae in genital infection, disease of the eye and Reiter's disease. Am J Ophthalmol (1967) 2.06

Ocular syndromes of TRIC virus infection and their possible genital significance. 1964. Sex Transm Infect (2000) 2.04

Infection of the eye, genitalia, and rectum by a new serotype (type G) of TRIC agent. Clinical and laboratory aspects. Br J Vener Dis (1973) 2.04

Triple-culture tests for diagnosis of chlamydial infection of the female genital tract. Sex Transm Dis (1985) 2.03

The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-kappa B function. J Immunol (1999) 2.03

Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol (1999) 1.97

New antibody in early syphilis. Lancet (1970) 1.97

Should exercise blood pressure be measured in clinical practice? J Hypertens (1998) 1.97

Human ehrlichiosis in the UK. Lancet (1995) 1.96

Immunological classification of TRIC agents and of some recently isolated LGV agents by the micro-immunofluorescence test. Br J Vener Dis (1972) 1.95

Relation of TRIC agent to "non-specific genital infection". Br J Vener Dis (1966) 1.94

Genetic and biochemical approach for characterization of resistance to Bacillus thuringiensis toxin Cry1Ac in a field population of the diamondback moth, Plutella xylostella. Appl Environ Microbiol (2000) 1.92

Management of infected aortoiliac aneurysms. Arch Surg (1991) 1.92

Observations on syphilis in Addis Ababa. 2. Prevalence and natural history. Br J Vener Dis (1977) 1.87

The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol (2002) 1.83